Germany· DE-A57-6f4fdc9c63d11af4
Kantos Nexthaler
A medicinal product containing formoterol fumarate dihydrate, beclometasone dipropionate anhydrous, registered in Germany by Chiesi Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous
- Manufacturer
- Chiesi Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Formoterol fumarate dihydrate, beclometasone dipropionate anhydrous in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBEKLOMETASON/FORMOTEROL CIPLACipla Europe NV, Antverpy
- SwedenAforbe 100 mikrogram/6 mikrogram/dos Inhalationsspray, lösningViatris Limited
- NetherlandsAmbofoz 100/6 microgram/dosis, aërosol, oplossingMedical Valley Invest AB
- United KingdomBibecfo 100micrograms/dose / 6micrograms/dose inhalerCipla EU Ltd
- FranceBECLOMETASONE/FORMOTEROL BIOGARAN 100/6 microgrammes/dose, solution pour inhalation en flacon pressuriséBIOGARAN
- PolandAeroxAdamed Pharma S.A.
- SpainBIBECFO 100 MICROGRAMOS/6 MICROGRAMOS/PULSACION SOLUCION PARA INHALACION EN ENVASE A PRESIONCipla Europe N.V.
- FinlandAforbeViatris Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aironis, Beclometason/Formoterol Cipla
- Belgium · Beclometasone/Formoterol Eg, Béclométasone/Formotérol Genetic
- Bulgaria · Beclometasone/Formoterol Pharmascience, Бефоза
- Cyprus · Beclometasone Formoterol Genetic, Brelung
- Czechia · Beclometason/Formoterol Cipla, Beklometason/Formoterol Cipla
- Denmark · Aforbe, Ambofoz
- Estonia · Aforbe, Bedufora
- Spain · Bibecfo, Blocetta
- Finland · Aforbe, Befoair
- France · Béclométasone/Formotérol Biogaran, Béclométasone/Formotérol Cipla
- United Kingdom (Northern Ireland) · Aeriluma, Formexa
- Greece · Beclometasone+formoterol Stada, Breair
- Croatia · Aforbe, Befodair
- Hungary · Forobex, Foster
- Ireland · Beclometasone/Formoterol, Fostair
- Iceland · Innovair, Laberon
- Italy · Alabaster, Beclometasone E Formoterolo Cipla
- Lithuania · Aforbe, Bedufora
- Luxembourg · Inuvair, Inuvair Nexthaler
- Latvia · Aforbe, Beclometasone/Formoterol Genetic
- Malta · Beclometasone Formoterol Genetic, Foster
- Netherlands · Ambofoz, Beclometason/Formoterol Allgen
- Norway · Aforbe, Ambofoz
- Poland · Aerox, Airiam
- Portugal · Beclofor, Beclometasona Formoterol Genetic
- Romania · Beclometazonă /Formoterol Stada, Beclometazona/Formoterol Cipla
- Sweden · Aforbe, Ambofoz
- Slovenia · Formodual, Foster
- Slovakia · Beklometazón/Formoterol Stada, Bibecfo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8cc6177-a005-49b7-8db6-44da24276ff1 GET /v1/drugs/e8cc6177-a005-49b7-8db6-44da24276ff1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Inhalation Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about formoterol fumarate dihydrate, beclometasone dipropionate anhydrous.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.